Mordechai Friedman - Net Worth and Insider Trading
Mordechai Friedman Net Worth
The estimated net worth of Mordechai Friedman is at least $0 dollars as of 2024-11-13. Mordechai Friedman is the Director of Brainstorm Cell Therapeutics Inc and owns about 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $0. Details can be seen in Mordechai Friedman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mordechai Friedman has not made any transactions after 2015-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mordechai Friedman
Mordechai Friedman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mordechai Friedman owns 1 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) .
Click here to see the complete history of Mordechai Friedman’s form 4 insider trades.
Insider Ownership Summary of Mordechai Friedman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2015-12-14 | director |
Mordechai Friedman Latest Holdings Summary
Mordechai Friedman currently owns a total of 1 stock. Mordechai Friedman owns 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of December 14, 2015, with a value of $0.
Latest Holdings of Mordechai Friedman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2015-12-14 | 0 | 1.18 | 0 |
Holding Weightings of Mordechai Friedman
Mordechai Friedman Form 4 Trading Tracker
According to the SEC Form 4 filings, Mordechai Friedman has made a total of 0 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years. The most-recent trade in Brainstorm Cell Therapeutics Inc is the sale of 333 shares on December 14, 2015, which brought Mordechai Friedman around $12,850.
Insider Trading History of Mordechai Friedman
- 1
Mordechai Friedman Trading Performance
Mordechai Friedman Ownership Network
Ownership Network List of Mordechai Friedman
Ownership Network Relation of Mordechai Friedman
Mordechai Friedman Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Mordechai Friedman is the director of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Mordechai Friedman made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Mordechai Friedman Mailing Address
Above is the net worth, insider trading, and ownership report for Mordechai Friedman. You might contact Mordechai Friedman via mailing address: C/o Brainstorm Cell Therapeutics, Inc., 110 East 59th Street, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
